Ulterior motives

On its own, Tony Clement's intention to look into whether Canadians are overcharged for generic drugs would be a good one. But given that it was Clement himself who handed a needless $300 million giveaway to brand-name drug manufacturers just a month ago, it's hard to see the effort as anything but a slap in the face of recognized Lib supporters (as opposed to a genuine effort to make medicine more affordable).